Stem Cell Theranostics is a precision medicine-focused biotechnology company developing genetically-targeted therapies for heart failure.Heart failure is a serious and growing medical concern. There is a critical need for translational preclinical models that address specific pathophysiology based on a patient's genetic profile. Through our exclusive relationship with the Stanford Cardiovascular Institute, we have built a discovery platform that can be used to develop genetically-targeted therapies and simultaneously assess cardiotoxicity.